Table 1.
Probiotic | Effect in epithelial barrier | Model | References |
---|---|---|---|
Bifidobacterium longum * | Increase the production of acetate and prevent the reduction in TEER resulting from E. coli O157-induced cell death. | Caco-2 | Fukuda et al., 2011, 2012 |
Bacteroides thetaiotaomicron * | Acetate-producing bacteria, favors goblet cell differentiation and mucus secretion. | Rats | Wrzosek et al., 2013 |
Faecalibacterium prausnitzii * | Acetate consumer and butyrate-producing bacteria, modulates the intestinal mucus barrier when supplemented in combination with B. thetaiotaomicron. | Rats | Wrzosek et al., 2013 |
Lactobacillus casei ** | Reverses the cytokine-induced dysfunction of TEER, epithelial permeability, and ZO-1 expression. | Caco-2 | Eun et al., 2011 |
B. animalis ssp. lactis CNCM-I2494** | Protects barrier integrity by restoring intestinal permeability, colonic goblet cell populations, and cytokine levels. Furthermore, normalizes the level of several TJ proteins, in particular claudin-4. | Mice | Martín et al., 2016 |
Lactobacillus plantarum ZLP001* | Modulates butyrate-producing enteric microbiota to induce the expression of epithelial host-defense peptides and to enhance intestinal Lactobacillus abundance to improve the gut microbiota composition and reinforce TJs. | Weaned piglets | Wang et al., 2018 |
L. acidophilus
*
Streptococcus thermophilus * |
Increases TEER, decreases permeability, and induces the activation of occludin and ZO-1, shown by increased levels of phosphorylated proteins. | Caco-2 HT-29 |
Resta-Lenert and Barrett, 2003 |
Probiotics that are part of the human intestinal microbiota.
Probiotics that, normally, are not present in the human intestinal microbiota.